Consensus Enlivex

Stocks

ENLV

IL0011319527

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-04 EDT			5-day change	1st Jan Change
2.110 ^USD	-2.76%		-5.80%	-80.00%

07-28	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

a6.wZZ6zRt9CO2rrlXcEJuyECn8f2f0Y98SBMd3DN4MX0U.kswxoVIzf4j5z2S3dPLqf1O-RhauBZNTZ5Y1SrhCC3SizAivSApSmf_cGA~9f41b7837640e80f9cda71696177243a

Analysts' recommendations: Enlivex

24-06-11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
24-04-12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
23-09-25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
22-05-02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

2.110USD

Average target price

80.00USD

Spread / Average Target

+3,691.47%

High Price Target

80.00USD

Spread / Highest target

+3,691.47%

Low Price Target

80.00USD

Spread / Lowest Target

+3,691.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

2.110USD

Average target price

80.00USD

Spread / Average Target

+3,691.47%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Stocks
ENLV Stock
Consensus Enlivex

The best tools reserved for subscribers to boost the performance of your investments!